http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005027515-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95eaed79dec59391549e8016815b3a8f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-91
filingDate 2003-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e7efe9a10e4e6f62eaa41081f347fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2e82e59737227e0bc7478d206c1570d
publicationDate 2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2005027515-A
titleOfInvention A method for differentiating sensitizing effects of hypoxic cell sensitizers and apoptotic signal-retaining agents under hypoxic conditions
abstract [PROBLEMS] To provide an in vitro differentiation method for the sensitizing effect of a hypoxic cell radiosensitizer that is simple and excellent in stability. A method for distinguishing a sensitizing effect of a hypoxic cell radiosensitizer used in radiotherapy for radiation-resistant cancer, wherein the cancer cell is compared with aerobic conditions under hypoxic conditions. A method for differentiating sensitizing effects of cancer cells using the degree of apoptosis and / or apoptosis signal in the presence and absence of a hypoxic cell radiosensitizer as an index. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8258165-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8202898-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541459-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8258166-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8450356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2019069891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008152764-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7353606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019069891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008090732-A1
priorityDate 2003-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466529964

Total number of triples: 25.